Tapewire

NYSE · USD

BSX

BOSTON SCIENTIFIC CORP

Export transactions ↓
Tapewire entity
1897
SEC CIK
0000885725
Parsed reports
1,285

Last 12 months

Inside the activity.

10 purchase rows · 7 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202501
Jan 202600
Feb 202602
Mar 202600
Apr 202600
May 202640
Jun 202600
Jul 202610
Aug 202650
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 07, 2024 Filed Oct 8, 2024 21:48 UTC
Mahoney Michael FDirector · Chairman, President & CEO
SaleCommon Stock 82,085 $84.94 $6,972,431.24
Disclosure

SEC source: 0001225208-24-009234 · doc4.xml · nonDerivative · entry 4

Mahoney Michael F · CIK 0001533022 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,572,096

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024.

F3 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $84.75 to $85.24, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 21:48 UTC
Mahoney Michael FDirector · Chairman, President & CEO
SaleCommon Stock 80,692 $84.31 $6,803,360.39
Disclosure

SEC source: 0001225208-24-009234 · doc4.xml · nonDerivative · entry 3

Mahoney Michael F · CIK 0001533022 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,654,181

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024.

F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $83.75 to $84.73, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 21:48 UTC
Mahoney Michael FDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 55,675 $16.31 $908,059.25
Disclosure

SEC source: 0001225208-24-009234 · doc4.xml · nonDerivative · entry 2

Mahoney Michael F · CIK 0001533022 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,734,873

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 21:48 UTC
Mahoney Michael FDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 56,211 $17.26 $970,201.86
Disclosure

SEC source: 0001225208-24-009234 · doc4.xml · nonDerivative · entry 1

Mahoney Michael F · CIK 0001533022 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,679,198

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 21:48 UTC
Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology
Exercise / conversionStock Option (Right to Buy) · Derivative 57,618 $0.00 Strike: $24.98 $0.00
Disclosure

SEC source: 0001225208-24-009233 · doc4.xml · derivative · entry 6

Fitzgerald Joseph Michael · CIK 0001484186 · EVP & Group Pres, Cardiology

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 57,618 shares

Expires 2027-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on May 23, 2024.

F5 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on March 3, 2018, the first anniversary of the date of grant.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 21:48 UTC
Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology
Exercise / conversionStock Option (Right to Buy) · Derivative 59,021 $0.00 Strike: $17.26 $0.00
Disclosure

SEC source: 0001225208-24-009233 · doc4.xml · derivative · entry 5

Fitzgerald Joseph Michael · CIK 0001484186 · EVP & Group Pres, Cardiology

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 59,021 shares

Expires 2026-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on May 23, 2024.

F4 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 21:48 UTC
Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology
SaleCommon Stock 132,527 $85.00 $11,264,887.77
Disclosure

SEC source: 0001225208-24-009233 · doc4.xml · nonDerivative · entry 3

Fitzgerald Joseph Michael · CIK 0001484186 · EVP & Group Pres, Cardiology

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 160,467

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on May 23, 2024.

F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.01, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 21:48 UTC
Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology
Exercise / conversionCommon Stock 57,618 $24.98 $1,439,297.64
Disclosure

SEC source: 0001225208-24-009233 · doc4.xml · nonDerivative · entry 2

Fitzgerald Joseph Michael · CIK 0001484186 · EVP & Group Pres, Cardiology

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 292,994

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on May 23, 2024.

Read SEC document
October 07, 2024 Filed Oct 8, 2024 21:48 UTC
Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology
Exercise / conversionCommon Stock 59,021 $17.26 $1,018,702.46
Disclosure

SEC source: 0001225208-24-009233 · doc4.xml · nonDerivative · entry 1

Fitzgerald Joseph Michael · CIK 0001484186 · EVP & Group Pres, Cardiology

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 235,376

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on May 23, 2024.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 20:22 UTC
Carruthers WendyEVP, Human Resources
Exercise / conversionStock Option (Right to Buy) · Derivative 1,197 $0.00 Strike: $24.55 $0.00
Disclosure

SEC source: 0001225208-24-009021 · doc4.xml · derivative · entry 5

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,577

Underlying: Common Stock · 1,197 shares

Expires 2027-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 20:22 UTC
Carruthers WendyEVP, Human Resources
Exercise / conversionStock Option (Right to Buy) · Derivative 3,066 $0.00 Strike: $17.26 $0.00
Disclosure

SEC source: 0001225208-24-009021 · doc4.xml · derivative · entry 4

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,132

Underlying: Common Stock · 3,066 shares

Expires 2026-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 20:22 UTC
Carruthers WendyEVP, Human Resources
SaleCommon Stock 6,983 $83.86 $585,594.38
Disclosure

SEC source: 0001225208-24-009021 · doc4.xml · nonDerivative · entry 3

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,748

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 20:22 UTC
Carruthers WendyEVP, Human Resources
Exercise / conversionCommon Stock 1,197 $24.55 $29,386.35
Disclosure

SEC source: 0001225208-24-009021 · doc4.xml · nonDerivative · entry 2

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,731

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 20:22 UTC
Carruthers WendyEVP, Human Resources
Exercise / conversionCommon Stock 3,066 $17.26 $52,919.16
Disclosure

SEC source: 0001225208-24-009021 · doc4.xml · nonDerivative · entry 1

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,534

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
September 05, 2024 Filed Sep 6, 2024 20:12 UTC
Mahoney Michael FDirector · Chairman, President & CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 55,675 $0.00 Strike: $16.31 $0.00
Disclosure

SEC source: 0001225208-24-008529 · doc4.xml · derivative · entry 6

Mahoney Michael F · CIK 0001533022 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 111,351

Underlying: Common Stock · 55,675 shares

Expires 2025-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024.

F4 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.

Read SEC document
September 05, 2024 Filed Sep 6, 2024 20:12 UTC
Mahoney Michael FDirector · Chairman, President & CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 56,211 $0.00 Strike: $17.26 $0.00
Disclosure

SEC source: 0001225208-24-008529 · doc4.xml · derivative · entry 5

Mahoney Michael F · CIK 0001533022 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 281,057

Underlying: Common Stock · 56,211 shares

Expires 2026-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024.

F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

Read SEC document
September 05, 2024 Filed Sep 6, 2024 20:12 UTC
Mahoney Michael FDirector · Chairman, President & CEO
SaleCommon Stock 162,777 $81.17 $13,212,543.98
Disclosure

SEC source: 0001225208-24-008529 · doc4.xml · nonDerivative · entry 3

Mahoney Michael F · CIK 0001533022 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,622,987

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024.

F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $80.52 to $81.80, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
September 05, 2024 Filed Sep 6, 2024 20:12 UTC
Mahoney Michael FDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 55,675 $16.31 $908,059.25
Disclosure

SEC source: 0001225208-24-008529 · doc4.xml · nonDerivative · entry 2

Mahoney Michael F · CIK 0001533022 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,785,764

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024.

Read SEC document
September 05, 2024 Filed Sep 6, 2024 20:12 UTC
Mahoney Michael FDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 56,211 $17.26 $970,201.86
Disclosure

SEC source: 0001225208-24-008529 · doc4.xml · nonDerivative · entry 1

Mahoney Michael F · CIK 0001533022 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,730,089

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024.

Read SEC document
September 03, 2024 Filed Sep 3, 2024 21:29 UTC
Carruthers WendyEVP, Human Resources
Exercise / conversionStock Option (Right to Buy) · Derivative 1,197 $0.00 Strike: $24.55 $0.00
Disclosure

SEC source: 0001225208-24-008333 · doc4.xml · derivative · entry 5

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,774

Underlying: Common Stock · 1,197 shares

Expires 2027-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

Read SEC document
September 03, 2024 Filed Sep 3, 2024 21:29 UTC
Carruthers WendyEVP, Human Resources
Exercise / conversionStock Option (Right to Buy) · Derivative 3,066 $0.00 Strike: $17.26 $0.00
Disclosure

SEC source: 0001225208-24-008333 · doc4.xml · derivative · entry 4

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,198

Underlying: Common Stock · 3,066 shares

Expires 2026-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

Read SEC document
September 03, 2024 Filed Sep 3, 2024 21:29 UTC
Carruthers WendyEVP, Human Resources
SaleCommon Stock 6,983 $81.70 $570,511.10
Disclosure

SEC source: 0001225208-24-008333 · doc4.xml · nonDerivative · entry 3

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,468

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
September 03, 2024 Filed Sep 3, 2024 21:29 UTC
Carruthers WendyEVP, Human Resources
Exercise / conversionCommon Stock 1,197 $24.55 $29,386.35
Disclosure

SEC source: 0001225208-24-008333 · doc4.xml · nonDerivative · entry 2

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,451

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
September 03, 2024 Filed Sep 3, 2024 21:29 UTC
Carruthers WendyEVP, Human Resources
Exercise / conversionCommon Stock 3,066 $17.26 $52,919.16
Disclosure

SEC source: 0001225208-24-008333 · doc4.xml · nonDerivative · entry 1

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,254

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
August 30, 2024 Filed Sep 3, 2024 21:28 UTC
Mahoney Michael FDirector · Chairman, President & CEO
GiftCommon Stock 176,245 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-008332 · doc4.xml · nonDerivative · entry 3

Mahoney Michael F · CIK 0001533022 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 209,278

F3 · kind: This transaction involved a gift of securities by the reporting person to The Michael F. Mahoney 2 Year Qualified Annuity Trust - 2024, which is administered by an independent trustee.

Read SEC document
August 30, 2024 Filed Sep 3, 2024 21:28 UTC
Mahoney Michael FDirector · Chairman, President & CEO
GiftCommon Stock 95,041 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-008332 · doc4.xml · nonDerivative · entry 2

Mahoney Michael F · CIK 0001533022 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 385,523

F2 · kind: This transaction involved a gift of securities by The Michael F. Mahoney 2 Year Qualified Annuity Trust - 2022, which is administered by an independent trustee.

Read SEC document
August 30, 2024 Filed Sep 3, 2024 21:28 UTC
Mahoney Michael FDirector · Chairman, President & CEO
GiftCommon Stock 114,237 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-008332 · doc4.xml · nonDerivative · entry 1

Mahoney Michael F · CIK 0001533022 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 290,482

F1 · kind: This transaction involved a gift of securities by The Michael F. Mahoney 2 Year Qualified Annuity Trust - 2023, which is administered by an independent trustee.

Read SEC document
August 28, 2024 Filed Aug 29, 2024 20:13 UTC
Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology
SaleCommon Stock 14,132 $80.00 $1,130,560.00
Disclosure

SEC source: 0001225208-24-008301 · doc4.xml · nonDerivative · entry 1

Fitzgerald Joseph Michael · CIK 0001484186 · EVP & Group Pres, Cardiology

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 176,355

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on May 23, 2024.

Read SEC document
August 26, 2024 Filed Aug 26, 2024 20:32 UTC
Butcher Arthur CEVP& Grp Pres, MedSurg & APAC
Exercise / conversionStock Option (Right to Buy) · Derivative 3,176 $0.00 Strike: $22.71 $0.00
Disclosure

SEC source: 0001225208-24-008198 · doc4.xml · derivative · entry 6

Butcher Arthur C · CIK 0001678249 · EVP& Grp Pres, MedSurg & APAC

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,883

Underlying: Common Stock · 3,176 shares

Expires 2026-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 22, 2023.

F5 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on June 1, 2017, the first anniversary of the date of grant.

Read SEC document
August 26, 2024 Filed Aug 26, 2024 20:32 UTC
Butcher Arthur CEVP& Grp Pres, MedSurg & APAC
Exercise / conversionStock Option (Right to Buy) · Derivative 1,009 $0.00 Strike: $17.26 $0.00
Disclosure

SEC source: 0001225208-24-008198 · doc4.xml · derivative · entry 5

Butcher Arthur C · CIK 0001678249 · EVP& Grp Pres, MedSurg & APAC

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,045

Underlying: Common Stock · 1,009 shares

Expires 2026-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 22, 2023.

F4 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

Read SEC document
August 26, 2024 Filed Aug 26, 2024 20:32 UTC
Butcher Arthur CEVP& Grp Pres, MedSurg & APAC
SaleCommon Stock 14,012 $79.25 $1,110,515.46
Disclosure

SEC source: 0001225208-24-008198 · doc4.xml · nonDerivative · entry 3

Butcher Arthur C · CIK 0001678249 · EVP& Grp Pres, MedSurg & APAC

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,802

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 22, 2023.

F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $78.8970 to $79.5900, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
August 26, 2024 Filed Aug 26, 2024 20:32 UTC
Butcher Arthur CEVP& Grp Pres, MedSurg & APAC
Exercise / conversionCommon Stock 1,009 $17.26 $17,415.34
Disclosure

SEC source: 0001225208-24-008198 · doc4.xml · nonDerivative · entry 2

Butcher Arthur C · CIK 0001678249 · EVP& Grp Pres, MedSurg & APAC

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,814

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 22, 2023.

Read SEC document
August 26, 2024 Filed Aug 26, 2024 20:32 UTC
Butcher Arthur CEVP& Grp Pres, MedSurg & APAC
Exercise / conversionCommon Stock 3,176 $22.71 $72,126.96
Disclosure

SEC source: 0001225208-24-008198 · doc4.xml · nonDerivative · entry 1

Butcher Arthur C · CIK 0001678249 · EVP& Grp Pres, MedSurg & APAC

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,805

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 22, 2023.

Read SEC document
August 06, 2024 Filed Aug 8, 2024 20:20 UTC
Butcher Arthur CEVP& Grp Pres, MedSurg & APAC
OtherCommon Stock 10,843 $73.76 $799,779.68
Disclosure

SEC source: 0001225208-24-007931 · doc4.xml · nonDerivative · entry 1

Butcher Arthur C · CIK 0001678249 · EVP& Grp Pres, MedSurg & APAC

10b5-1 filing: No plan indicated

Ownership: Indirect · By 401(k)

Disclosed balance after: 13,381

F1 · kind: Acquistion made pursuant to an election by the reporting person to rebalance their holdings under the Company's 401(k) Retirement Savings Plan, which resulted in a discretionary transaction in shares of the Company's common stock.

F2 · balance_after: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.

Read SEC document
August 01, 2024 Filed Aug 1, 2024 21:13 UTC
Carruthers WendyEVP, Human Resources
Exercise / conversionStock Option (Right to Buy) · Derivative 1,197 $0.00 Strike: $24.55 $0.00
Disclosure

SEC source: 0001225208-24-007778 · doc4.xml · derivative · entry 5

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,971

Underlying: Common Stock · 1,197 shares

Expires 2027-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

Read SEC document
August 01, 2024 Filed Aug 1, 2024 21:13 UTC
Carruthers WendyEVP, Human Resources
Exercise / conversionStock Option (Right to Buy) · Derivative 3,066 $0.00 Strike: $17.26 $0.00
Disclosure

SEC source: 0001225208-24-007778 · doc4.xml · derivative · entry 4

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,264

Underlying: Common Stock · 3,066 shares

Expires 2026-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

Read SEC document
August 01, 2024 Filed Aug 1, 2024 21:13 UTC
Carruthers WendyEVP, Human Resources
SaleCommon Stock 6,983 $74.12 $517,579.96
Disclosure

SEC source: 0001225208-24-007778 · doc4.xml · nonDerivative · entry 3

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,188

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
August 01, 2024 Filed Aug 1, 2024 21:13 UTC
Carruthers WendyEVP, Human Resources
Exercise / conversionCommon Stock 1,197 $24.55 $29,386.35
Disclosure

SEC source: 0001225208-24-007778 · doc4.xml · nonDerivative · entry 2

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,171

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
August 01, 2024 Filed Aug 1, 2024 21:13 UTC
Carruthers WendyEVP, Human Resources
Exercise / conversionCommon Stock 3,066 $17.26 $52,919.16
Disclosure

SEC source: 0001225208-24-007778 · doc4.xml · nonDerivative · entry 1

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 45,974

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 20:43 UTC GrantCommon Stock 1,252 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-007847 · doc4.xml · nonDerivative · entry 2

Habiger David C · CIK 0001326409 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,547

F2 · price: Grant of restricted stock in lieu of 100% yearly cash compensation, following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2025 annual meeting of stockholders. Reflects a value of approximately $94,175 (representing 100% of the prorated amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 20:43 UTC GrantCommon Stock 2,155 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-007847 · doc4.xml · nonDerivative · entry 1

Habiger David C · CIK 0001326409 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,295

F1 · price: Grant of restricted stock to non-employee director following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2025 annual meeting of stockholders. The grant of restricted stock vests in full upon the next annual meeting of stockholders. Reflects a value of approximately $161,981 (representing 100% of the prorated amount of the non-employee director compensation program's annual equity award having a value of $215,000) divided by the closing price of common stock on the date of grant.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:13 UTC
Brown Vance RSVP, GC and Corp. Secretary
Exercise / conversionRestricted Stock Units · Derivative 4,036 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-007198 · doc4.xml · derivative · entry 3

Brown Vance R · CIK 0001868243 · SVP, GC and Corp. Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,036

Underlying: Common Stock · 4,036 shares

Expires 2025-07-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2 · derivative.exercise_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2022, the first anniversary of the date of grant.

F2 · derivative.expiration_date: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2022, the first anniversary of the date of grant.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:13 UTC
Brown Vance RSVP, GC and Corp. Secretary
Tax withholdingCommon Stock 1,952 $76.41 $149,152.32
Disclosure

SEC source: 0001225208-24-007198 · doc4.xml · nonDerivative · entry 2

Brown Vance R · CIK 0001868243 · SVP, GC and Corp. Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,410

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:13 UTC
Brown Vance RSVP, GC and Corp. Secretary
Exercise / conversionCommon Stock 4,036 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-007198 · doc4.xml · nonDerivative · entry 1

Brown Vance R · CIK 0001868243 · SVP, GC and Corp. Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,362

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:13 UTC
Carruthers WendyEVP, Human Resources
Exercise / conversionStock Option (Right to Buy) · Derivative 1,197 $0.00 Strike: $24.55 $0.00
Disclosure

SEC source: 0001225208-24-007196 · doc4.xml · derivative · entry 5

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,168

Underlying: Common Stock · 1,197 shares

Expires 2027-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:13 UTC
Carruthers WendyEVP, Human Resources
Exercise / conversionStock Option (Right to Buy) · Derivative 3,066 $0.00 Strike: $17.26 $0.00
Disclosure

SEC source: 0001225208-24-007196 · doc4.xml · derivative · entry 4

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,330

Underlying: Common Stock · 3,066 shares

Expires 2026-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F2 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:13 UTC
Carruthers WendyEVP, Human Resources
SaleCommon Stock 6,983 $77.30 $539,785.90
Disclosure

SEC source: 0001225208-24-007196 · doc4.xml · nonDerivative · entry 3

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,908

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:13 UTC
Carruthers WendyEVP, Human Resources
Exercise / conversionCommon Stock 1,197 $24.55 $29,386.35
Disclosure

SEC source: 0001225208-24-007196 · doc4.xml · nonDerivative · entry 2

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 49,891

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:13 UTC
Carruthers WendyEVP, Human Resources
Exercise / conversionCommon Stock 3,066 $17.26 $52,919.16
Disclosure

SEC source: 0001225208-24-007196 · doc4.xml · nonDerivative · entry 1

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,694

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

Read SEC document
June 03, 2024 Filed Jun 3, 2024 21:39 UTC
Carruthers WendyEVP, Human Resources
Exercise / conversionStock Option (Right to Buy) · Derivative 1,197 $0.00 Strike: $24.55 $0.00
Disclosure

SEC source: 0001225208-24-006513 · doc4.xml · derivative · entry 5

Carruthers Wendy · CIK 0001563565 · EVP, Human Resources

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,365

Underlying: Common Stock · 1,197 shares

Expires 2027-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.

F3 · derivative.exercise_date: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.